AIRLINK 73.00 Decreased By ▼ -2.16 (-2.87%)
BOP 5.35 Decreased By ▼ -0.10 (-1.83%)
CNERGY 4.31 Decreased By ▼ -0.08 (-1.82%)
DFML 28.55 Increased By ▲ 0.91 (3.29%)
DGKC 74.29 Increased By ▲ 2.29 (3.18%)
FCCL 20.35 Increased By ▲ 0.06 (0.3%)
FFBL 30.90 Decreased By ▼ -0.15 (-0.48%)
FFL 10.06 Increased By ▲ 0.09 (0.9%)
GGL 10.39 Increased By ▲ 0.12 (1.17%)
HBL 115.97 Increased By ▲ 0.97 (0.84%)
HUBC 132.20 Increased By ▲ 0.75 (0.57%)
HUMNL 6.68 Decreased By ▼ -0.19 (-2.77%)
KEL 4.03 Decreased By ▼ -0.17 (-4.05%)
KOSM 4.60 Decreased By ▼ -0.17 (-3.56%)
MLCF 38.54 Increased By ▲ 1.46 (3.94%)
OGDC 133.85 Decreased By ▼ -1.60 (-1.18%)
PAEL 23.83 Increased By ▲ 0.43 (1.84%)
PIAA 27.13 Decreased By ▼ -0.18 (-0.66%)
PIBTL 6.76 Increased By ▲ 0.16 (2.42%)
PPL 112.80 Decreased By ▼ -0.36 (-0.32%)
PRL 28.16 Decreased By ▼ -0.59 (-2.05%)
PTC 14.89 Decreased By ▼ -0.61 (-3.94%)
SEARL 56.42 Decreased By ▼ -0.91 (-1.59%)
SNGP 65.80 Decreased By ▼ -1.19 (-1.78%)
SSGC 11.01 Decreased By ▼ -0.16 (-1.43%)
TELE 9.02 Decreased By ▼ -0.12 (-1.31%)
TPLP 11.90 Decreased By ▼ -0.15 (-1.24%)
TRG 69.10 Decreased By ▼ -1.29 (-1.83%)
UNITY 23.71 Increased By ▲ 0.06 (0.25%)
WTL 1.33 Decreased By ▼ -0.01 (-0.75%)
BR100 7,434 No Change 0 (0%)
BR30 24,220 No Change 0 (0%)
KSE100 71,359 No Change 0 (0%)
KSE30 23,567 No Change 0 (0%)

firdous-ashiq-awanISLAMABAD: Federal Minister for National Regulation and Services Dr. Firdous Ashiq Awan here on Sunday said that a fast track plan of action had been introduced by the Drug Regulation Authority (DRA) for registration of 14,000 pending drugs at the earliest.

 

Elaborating details of the policy, Dr. Firdous said that those pharmaceutical companies, who wanted to register their drugs at the earliest, could pay double or triple fee for the purpose.

 

"We have taken this step to generate resources for the authority and also clear the backlog of 14,000 pending drug registration applications with the cooperation of pharmaceutical companies", the minister stated.

 

She said the newly established Drug Regulatory Authority was an autonomous body which was facing a number of problems, including financial constraints and pressure for registration of drugs so the new strategy had been established with the consensus of all the departments concerned.

 

She said that the policy board had finalized appointment criteria of Chief Executive Officer of the authority and it was their utmost endeavour to select a qualified, competent, professional and committed person for this seat before the expiry of their tenure.

 

"It is imperative to appoint a most suitable, competent, committed, professional and dedicated person on this seat as medicines are basic requirement of masses and our focus is to facilitate people at their doorsteps", she added.

 

He said the prime responsibility of the authority was to address the issues of pricing, quality and distribution of medicines across the country as the government was committed to provide safe, effective, quality and economically affordable drugs and medicines to the people.

 

In order to make an effective authority the minister highlighted that new section including information technology, alternate medicine finance legal and controlled drugs had been created to meet international commitments, enhanced coordination and to bring harmony in interprovincial trade and commerce of therapeutic goods.

 

Copyright APP (Associated Press of Pakistan), 2013

Comments

Comments are closed.